{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:08:29Z","timestamp":1778458109661,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781071650363","type":"print"},{"value":"9781071650370","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5037-0_10","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:22:16Z","timestamp":1778455336000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of T Cell Migration by T Cell-Dependent Bispecific Antibody in Cancer Cells and T Cell Cross-Linking"],"prefix":"10.1007","author":[{"given":"Rikuto","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-med-062617-035821","volume":"70","author":"RA Clynes","year":"2019","unstructured":"Clynes RA, Desjarlais JR (2019) Redirected T cell cytotoxicity in cancer therapy. Annu Rev Med 70:437\u2013450","journal-title":"Annu Rev Med"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fimmu.2020.00762","volume":"11","author":"M Lejeune","year":"2020","unstructured":"Lejeune M, K\u00f6se MC, Duray E et al (2020) Bispecific, T-cell-recruiting antibodies in B-cell malignancies. Front Immunol 11:762","journal-title":"Front Immunol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/cancers13020287","volume":"13","author":"J Middelburg","year":"2021","unstructured":"Middelburg J, Kemper K, Engelberts P et al (2021) Overcoming challenges for CD3-bispecific antibody therapy in solid tumors. Cancers (Basel) 13:287","journal-title":"Cancers (Basel)"},{"key":"10_CR4","doi-asserted-by":"crossref","unstructured":"Golubovskaya V, Sienkiewicz J, Sun J et al (2023) mRNA-lipid nanoparticle (LNP) delivery of humanized EpCAM-CD3 bispecific antibody significantly blocks colorectal cancer tumor growth. Cancers 15","DOI":"10.3390\/cancers15102860"},{"key":"10_CR5","doi-asserted-by":"crossref","unstructured":"Kemper K, Gielen E, Boross P et al (2022) Mechanistic and pharmacodynamic studies of\u00a0DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance 5","DOI":"10.26508\/lsa.202201481"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00262-020-02667-9","volume":"70","author":"D Kamakura","year":"2021","unstructured":"Kamakura D, Asano R, Kawai H, Yasunaga M (2021) Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation. Cancer Immunol Immunother 70:177\u2013188","journal-title":"Cancer Immunol Immunother"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"e55532","DOI":"10.15252\/embr.202255532","volume":"24","author":"P Himmels","year":"2023","unstructured":"Himmels P, Nguyen TTT, Mitzner MC et al (2023) T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction. EMBO Rep 24:e55532","journal-title":"EMBO Rep"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jconrel.2023.01.041","volume":"354","author":"D Liu","year":"2023","unstructured":"Liu D, Bao L, Zhu H et al (2023) Microenvironment-responsive anti-PD-L1 \u00d7 CD3 bispecific T-cell engager for solid tumor immunotherapy. J Control Release 354:606\u2013614","journal-title":"J Control Release"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"575737","DOI":"10.3389\/fonc.2020.575737","volume":"10","author":"J Sam","year":"2020","unstructured":"Sam J, Colombetti S, Fauti T et al (2020) Combination of T-cell bispecific antibodies with\u00a0PD-L1 checkpoint inhibition elicits superior anti-tumor activity. Front Oncol 10:575737","journal-title":"Front Oncol"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"e0241091","DOI":"10.1371\/journal.pone.0241091","volume":"16","author":"F Cremasco","year":"2021","unstructured":"Cremasco F, Menietti E, Speziale D et al (2021) Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFN\u03b3\/CXCL10-dependent peripheral T cell recruitment in humanized murine model. PLoS One 16:e0241091","journal-title":"PLoS One"},{"key":"10_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48711-2","volume":"9","author":"R Khazen","year":"2019","unstructured":"Khazen R, M\u00fcller S, Lafouresse F et al (2019) Sequential adjustment of cytotoxic T lymphocyte densities improves efficacy in controlling tumor growth. Sci Rep 9: 12308","journal-title":"Sci Rep"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"1599635","DOI":"10.1080\/2162402X.2019.1599635","volume":"8","author":"N Nelson","year":"2019","unstructured":"Nelson N, Lopez-Pelaez M, Palazon A et al (2019) A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity. Oncoimmunology 8:1599635","journal-title":"Oncoimmunology"}],"container-title":["Methods in Molecular Biology","Bispecific Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5037-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:22:17Z","timestamp":1778455337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5037-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650363","9781071650370"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}